New perspectives on the management of septic shock in the cancer patient

Infectious Disease Clinics of North America

Volumn 10, Issue 2, 1996, Pages 239-253

  Toney, J F ^a   Parker, M M ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE FACTOR; INOTROPIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEVER; FLUID THERAPY; HEART EJECTION FRACTION; HEART INDEX; HEART MUSCLE CONTRACTILITY; HUMAN; INFECTION; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; RAT; REVIEW; SEPTIC SHOCK; SYSTEMIC VASCULAR RESISTANCE; TACHYCARDIA; TACHYPNEA;

EID: 0029948034     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70298-1     Document Type: Article

References (95)

1. E. Abraham W.C. Shoemaker R.D. Bland Sequential cardiorespiratory patterns in septic shock Crit Care Med 11 1983 799 803
2. A.J. Ahmed J.A. Kruse M.T. Haupt Hemodynamic responses to Gram-positive versus Gram-negative sepsis in critically ill patients with and without circulatory shock Crit Care Med 19 1991 1520 1525
3. M.E. Astiz E.C. Rackow J.L. Falk Oxygen delivery and consumption in patients with hyperdynamic septic shock Crit Care Med 15 1987 26 28
4. A.L. Beal F.B. Cerra Multiple organ failure syndrome in the 1990s JAMA 271 1994 226 233
5. B. Beutler A. Cerami Tumor necrosis factor, cachexia, shock, and inflammation: A common mediator Annu Rev Biochem 57 1988 505 518
6. A. Billiau F. Vanderkerckhove Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock Eur J Clin Invest 21 1991 559 573
7. R.C. Bone Gram-positive organisms and sepsis Arch Intern Med 154 1994 26 34
8. R.C. Bone R.A. Balk F.B. Cerra Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Chest 101 1992 1644 1655
9. R.C. Bone R.A. Balk A.M. Fein A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: Results of a prospective, multicenter, randomized, controlled trial Crit Care Med 23 1995 994 1005
10. R.C. Bone C.J. Fisher T.P. Clemmer A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock N Engl J Med 317 1987 653 658
11. C.F. Bryan R.V. Harrison Appropriate initial antimicrobial therapy of severe sepsis Infections in Medicine 11 1994 372
12. L.C. Casey R.A. Balk R.C. Bone Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome Ann Intern Med 119 1993 771 778
13. Control Center for Disease Increase in national hospital discharge survey rates for septicemia-United States, 1979-1987 MMWR 39 1990 31
14. J.W. Christman E.P. Holden T.S. Blackwell Strategies for blocking the systemic effects of cytokines in the sepsis syndrome Crit Care Med 23 1995 955 963
15. T.P. Clemmer C.J. Fisher R.C. Bone Hypothermia in the sepsis syndrome and clinical outcome Crit Care Med 20 1992 1395 1401
16. J.P. Cobb R.E. Cunnion R.L. Danner Nitric oxide as a target for therapy in septic shock Crit Care Med 21 1993 1261 1263
17. w-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin J Exp Med 176 1992 1175 1182
18. R.E. Cunnion G.L. Schaer M.M. Parker The coronary circulation in human septic shock Circulation 73 1986 637 644
19. R.L. Danner R.J. Elin J.M. Hosseini Endotoxemia in human septic shock Chest 99 1991 169 175
20. P. Dejars M. Pinaud G. Potel A reappraisal of norepinephrine therapy in human septic shock Crit Care Med 15 1987 134 137
21. J.F. Dhainaut M.F. Huyghebaert J.F. Monsallier Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock Circulation 75 1987 533 541
22. J.D. Edwards G.C.S. Brown P. Nightingale Use of survivors' cardiorespiratory values as therapeutic goals in septic shock Crit Care Med 17 1989 1098 1103
23. A.G. Ellrodt M.S. Riedinger A. Kimchi Left ventricular performance in septic shock: Reversible segmental and global abnormalities Am Heart J 110 1985 402 409
24. R.S. Escuro M. Jacobs S.L. Gerson Prospective evaluation of a Candida antigen detection test for invasive candidiasis in immunocompromised adult patients with cancer Am J Med 87 1989 621 627
25. M.S. Finkel C.V. Oddis T.D. Jacob Negative inotropic effects of cytokines on the heart mediated by nitric oxide Science 257 1992 387 389
26. C.J. Fisher J.F.A. Dhainaut S.M. Opal Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome JAMA 271 1994 1836 1843
27. C.J. Fisher S.M. Opal J.F. Dhainaut Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis Crit Care Med 21 1993 318 327
28. C.J. Fisher G.J. Slotman S.M. Opal Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebo-controlled multicenter trial Crit Care Med 22 1994 12 21
29. B. Fleischer Stimulation of human T cells by microbial superantigens Immunol Res 10 1991 349 355
30. T. Fukuoka M. Nishiura H. Imanaka Effects of norepinephrine on renal function in septic patients with normal and elevated serum lactate levels Crit Care Med 17 1989 1104 1107
31. E.M. Gilbert M.T. Haupt R.Y. Mandanas The effect of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis Am Rev Respir Dis 134 1986 873 878
32. R.L. Greenman R.M. Schein M.A. Martin A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis JAMA 266 1991 1097 1102
33. A.B.J. Groeneveld L.G. Thijs Pulmonary artery catheterisation in septic shock: Indications; therapeutic and prognostic implications Clinics of Intensive Care 1 1990 111 115
34. S.O. Heard M.W. Perkins M.P. Fink Tumor necrosis factor-alpha causes myocardial depression in guinea pigs Crit Care Med 20 1992 523 527
35. L.B. Hinshaw B.K. Beller-Todd L.T. Archer Review update: Current management of the septic shock patient: Experimental basis for treatment Circulatory Shock 9 1982 543 553
36. W.T. Hughes D. Armstrong G.P. Bodey Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever J Infect Dis 161 1990 381 396
37. T. Ikejima S. Okusawa J.W.M. VanDerMeer Toxic shock syndrome is mediated by interleukin 1 and tumor necrosis factor Reviews of Infectious Diseases 11 1989 S316
38. F. Jardin D. Brun-Ney B. Auvert Sepsis-related cardiogenic shock Crit Care Med 18 1990 1055 1060
39. G-monomethyl-L-arginine restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock Biochem Biophys Res Commun 178 1991 1135 1140
40. B.E. Kreger D.E. Craven W.R. McCabe Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients Am J Med 68 1980 344 355
41. A. Kumar C. Dimou J. Snell Tumor necrosis factor produces depression of myocardial cell contraction in vitro Crit Care Med 20 1992 S52
42. A. Kumar R. Kosuri P. Kandula Cardiomyocyte depression induced by human septic serum is mediated by nitric oxide and cyclic GMP generation Crit Care Med 22 1994 A119
43. M.D. Laufe R.H. Simon A. Flint Adult respiratory distress syndrome in neutropenic patients Am J Med 80 1986 1022 1026
44. S. Lautenschlager C. Herzog W. Zimmerli Course and outcome of bacteremia due to Staphylococcus aureus Evaluation of different clinical case definitions Clin Infect Dis 16 1993 567
45. M. Levi H. en Cate T. van der Poll Pathogenesis of disseminated intravascular coagulation in sepsis JAMA 270 1993 975 979
46. T.C.M. Li M.C. Phillips L. Shaw On-site physician staffing in a community hospital intensive care unit: Impact on test and procedure use and on patient outcome JAMA 252 1984 2023 2027
47. J.A. Lorente L. Landin R. De Pablo L-arginine pathway in the sepsis syndrome Crit Care Med 21 1993 1287 1295
48. J.A. Lorente L. Landin E. Renes Role of nitric oxide in the hemodynamic changes of sepsis Crit Care Med 21 1993 759 767
49. J.M. Luce Introduction of new technology into critical care practice: A history of HA-1A human monoclonal antibody against endotoxin Crit Care Med 21 1993 1233 1241
50. W.A. Lynn J. Cohen Adjunctive therapy for septic shock: A review of experimental approaches Clin Infect Dis 20 1995 143 158
51. E.F. Manzullo Sepsis, the role of steroids and monoclonal antibodies in treatment Oncology 8 1994 115 120
52. P. Martino C. Girmenia M. Venditti Candida colonization and systemic infection in neutropenic patients Cancer 64 1989 2030 2034
53. T. Mitsuo S. Shimazaki H. Matsuda Right ventricular dysfunction in septic patients Crit Care Med 20 1992 630 634
54. MMWR: Increase in national hospital discharge survey rates for septicemia United States, 1979-1987 MMWR 39 1990 31 34
55. H.W. Murray Cytokines as antimicrobial therapy for the T cell-deficient patient; prospects for treatment of nonviral opportunistic infection Clin Infect Dis 17 1993 S407
56. S.A. Nasraway E.C. Rackow M.E. Astiz Inotropic response to digoxin and dopamine in patients with severe sepsis, cardiac failure, and systemic hypoperfusion Chest 95 1989 612 615
57. C. Natanson W.D. Hoffman A.F. Suffredini Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis Ann Intern Med 120 1994 771 783
58. G-monomethyl-L-arginine J Cardiovasc Pharmacol 20 suppl 12 1992 S132 S134
59. F.P. Ognibene S.E. Martin M.M. Parker Adult respiratory distress syndrome in patients with severe neutropenia N Engl J Med 315 1986 547 551
60. F.P. Ognibene M.M. Parker C. Natanson Depressed left ventricular performance: Response to volume infusion in patients with sepsis and septic shock Chest 93 1988 903 910
61. K. Ohlsson P. Bjork M. Bergenfeldt Interleukin-1 receptor antagonist reduces mortality from endotoxin shock Nature 348 1990 550 552
62. R.D. Olson D.L. Stevens M.E. Melish Direct effects of purified Staphylococcal toxic shock syndrome toxin 1 on myocardial function of isolated rabbit atria Rev Infect Dis 11 1989 S313
63. M.I. Packman E.C. Rackow Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock Crit Care Med 11 1983 165 169
64. M.M. Parker K.E. McCarthy F.P. Ognibene Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans Chest 97 1990 126 131
65. M.M. Parker F.P. Ognibene P. Rogers Severe Pneumocystis carinii pneumonia produces a hyperdynamic profile similar to bacterial pneumonia with sepsis Crit Care Med 22 1994 50 54
66. M.M. Parker J.H. Shelhamer S.L. Bacharach Profound but reversible myocardial depression in patients with septic shock Ann Intern Med 100 1984 483 490
67. M.M. Parker J.H. Shelhamer C. Natanson Serial cardiovascular patterns in survivors and nonsurvivors of human septic shock: Heart rate as an early predictor of prognosis Crit Care Med 15 1987 923 929
68. J.E. Parrillo C. Burch J.H. Shelhamer A circulating myocardial depressant substance in humans with septic shock J Clin Invest 76 1985 1539 1533
69. J.E. Pennington Therapy with antibody to tumor necrosis factor in sepsis Clin Infect Dis 17 1993 S515
70. W.P. Peters Use of cytokines during prolonged neutropenia associated with autologous bone marrow transplantation Reviews of Infectious Disease 13 1991 23 31
71. A. Petros D. Bennett P. Vallance Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock Lancet 338 1991 1557 1558
72. P.A. Pizzo K.J. Robichaud F.A. Gill Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia Am J Med 72 1982 101 111
73. E.C. Rackow B.S. Kaufman J.L. Falk Hemodynamic response to fluid repletion in patients with septic shock: Evidence for early depression of cardiac performance Circulatory Shock 22 1987 11 22
74. R. Raper W.J. Sibbald A.A. Driedger Relative myocardial depression in normotensive sepsis J Crit Care 4 1989 9 18
75. J.M. Reilly R.E. Cunnion C. Burch-Whitman A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock Chest 95 1989 1072 1080
76. E. Roilides P.A. Pizzo Modulation of host defenses by cytokines; evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts Clin Infect Dis 15 1992 508 524
77. E. Roilides P.A. Pizzo Perspectives on the use of cytokines in the management of infectious complications of cancer Clin Infect Dis 17 1993 S385
78. P.M. Schlievert Role of the staphylococcal and streptococcal pyrogenic-toxin superantigens in human disease Mediguide Infect Dis 13 1993 1
79. A.J. Schneider G.J.J. Teule A.B.J. Groeneveld Biventricular performance during volume loading in patients with early septic shock, with emphasis on the right ventricle: A combined hemodynamic and radionuclide study Am Heart J 116 1988 103 112
80. J.L. Shenep Empiric antimicrobial treatment in febrile neutropenic cancer patients Infections in Medicine 9 1992 39 47
81. H.J. Silverman R. Penaranda J.B. Orens Impaired β-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: Association with myocardial hyporesponsiveness to catecholamines Crit Care Med 21 1993 31 39
82. G.J. Slotman C.J. Fisher R.C. Bone Detrimental effects of high-dose methylprednisolone sodium succinate on serum concentrations of hepatic and renal function indicators in severe sepsis and septic shock Crit Care Med 21 1993 191 195
83. The Veterans Administration Systemic Sepsis Cooperative Study Group Effect of highdose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis N Engl J Med 317 1987 659 665
84. F. Thomas J.L. Smith J.F. Orme Reversible segmental myocardial dysfunction in septic shock Crit Care Med 14 1986 587 588
85. J.K. Todd A. Franco-Buff D.W. Lawellin Phenotypic distinctiveness of Staphylococcus aureus strains associated with toxic shock syndrome Infect Immun 45 1984 339 344
86. J. Tuchschmidt J. Fried M. Astiz Elevation of cardiac output and oxygen delivery improves outcome in septic shock Chest 102 1992 216 220
87. C.G. Vermeij B.W.A. Feenstra W.J. Adrichem Independent oxygen uptake and oxygen delivery in septic and postoperative patients Chest 99 1991 1438 1443
88. J.L. Vincent J. Bakker Marecaux Gaetan Administration of anti-TNF antibody improves left ventricular function in septic shock patients Chest 101 1992 810 815
89. J.L. Vincent A. Roman R.J. Kahn Dobutamine administration in septic shock: Addition to a standard protocol Crit Care Med 18 1990 689 693
90. R.P. Wenzel Anti-endotoxin monoclonal antibodies a second look N Engl J Med 326 1992 1151 1152
91. F. Wilson Surgical intensive care units J.E. Parrillo S.M. Ayes Major Issues in Critical Care Medicine 1984 Williams and Wilkins Baltimore 17 33
92. R.F. Wilson W.J. Sibbald J.L. Jaanimagi Hemodynamic effects of dopamine in critically ill septic patients J Surg Res 20 1976 163 172
93. M. Yu M.M. Levy P. Smith Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients. A prospective, randomized, controlled study Crit Care Med 21 1993 830 838
94. G. Zanetti D. Heumann J. Gerain Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice: comparative protective efficacy of antibodies to tumor necrosis factor α and to lipopolysaccharide J Immunol 148 1992 1890 1897
95. E.J. Ziegler C.J. Fisher C.L. Sprung Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin N Engl J Med 324 1991 429 436